The recent surge in funding into specialized pharmaceutical companies, particularly those focusing on novel therapies and challenging drug development programs, has fueled what some are calling "High Roller Pharma." https://larissaunch813056.bloggin-ads.com/63235934/high-stakeholder-pharma-a-hazardous-wager